Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galapagos NV ADR
(NQ:
GLPG
)
28.80
-0.32 (-1.10%)
Streaming Delayed Price
Updated: 2:40 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Galapagos NV ADR
< Previous
1
2
3
4
Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Upgrades
Via
Benzinga
Where Galapagos Stands With Analysts
September 09, 2022
Analysts have provided the following ratings for Galapagos (NASDAQ:GLPG) within the last quarter:
Via
Benzinga
Lyft, DoorDash, Expedia And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 05, 2022
Atlas Corp. (NYSE: ATCO) rose 21.4% to $14.06 in pre-market trading after the company said it received a non-binding proposal from Poseidon Acquisition Corp. to acquire all outstanding common shares of...
Via
Benzinga
Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field
June 22, 2022
Via
Benzinga
Galapagos In-licenses Inflammatory Bowel Disease Drug Targets From Scipher Medicine
May 24, 2022
Via
Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
RBC Expects Business Development To Unlock This Pharma Stock's Balance Sheet Value
May 09, 2022
RBC Capital Markets views Galapagos' NV (NASDAQ: GLPG) Q1 Jyseleca revenues in line as the story focuses on whether new leadership can unlock value from GLPG's ample balance sheet.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...
Via
Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 31, 2022
Gainers Madrigal Pharmaceuticals (NASDAQ:MDGL) shares rose 14.9% to $64.8 during Monday's pre-market session. The market value of their outstanding shares is at $1.1...
Via
Benzinga
Mid-Afternoon Market Update: US Stocks Turns Lower In Volatile Trading; Nasdaq Tumbles 150 Points
January 27, 2022
US stocks turned lower in another volatile trading session on Thursday despite stronger-than-expected GDP data. The country’s economy grew 6.9% on quarter during the last...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 27, 2022
Gainers Galapagos (NASDAQ:GLPG) stock rose 21.4% to $64.75 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.5 million, which is...
Via
Benzinga
Mid-Day Market Update: Dow Jumps Over 500 Points; Seagate Shares Surge On Upbeat Results
January 27, 2022
The Dow Jones extended gains, surging by more than 500 points. The country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3%...
Via
Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 158.2% to $7.23 after tumbling 18% on Wednesday. Indonesia Energy said it projects to commence drilling...
Via
Benzinga
Mid-Morning Market Update: US Markets Open Higher As GDP Rises 6.9% In Fourth Quarter
January 27, 2022
US stocks opened on a strong note on Thursday after the country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 27, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4...
Via
Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
January 27, 2022
Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!
Via
InvestorPlace
26 Stocks Moving in Thursday's Pre-Market Session
January 27, 2022
Gainers The National Security Group, Inc. (NASDAQ: NSEC) rose 63.7% to $15.10 in pre-market trading after VR Insurance Holdings announced acquisition of The National...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 26, 2022
Gainers Reneo Pharmaceuticals (NASDAQ:RPHM
Via
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)...
Via
Benzinga
recession in 2022?
December 06, 2021
China has cut its reserve requirement for lending by 50% giving a $188 bn boost to its market.
Via
Talk Markets
Topics
Economy
Exposures
Economy
Monday Market Coverage
November 15, 2021
Gold is up today on inflation fears.
Via
Talk Markets
Galapagos NV (GLPG) Q3 2021 Earnings Call Transcript
November 05, 2021
GLPG earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.